NYSE:RFL   Rafael Holdings, Inc
Suspecting approval of Rafael’s lead AMD compound, CPI-613® (devimistat).

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.